InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Puromycin | Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vi... | 2021 | EBioMedicine | Huang H.C. et al. | DOI: 10.1016/j.ebiom.2021.103712 |
| Plasmocure™ - Mycoplasma Elimination Reagent | Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Co... | 2021 | Clin Lab Anal | Hayashi K. et al. | DOI: 10.1002/jcla.24146 |
| Primocin® | High-throughput ex vivo drug testing identifies potential drugs and drug comb... | 2021 | Transl Oncol | Kohtamäki L. et al. | DOI: 10.1016/j.tranon.2021.101290 |
| CD 20 | Block-Removed Immunoglobulin Technology to enhance rituximab effector functio... | 2021 | Oncol Lett | Grasso L. et al. | DOI: 10.3892/ol.2021.13120 |
| ODN 2395 VacciGrade™ | An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit... | 2021 | Vaccines (Basel) | Cao H. et al. | DOI: 10.3390/vaccines9111261 |
| c-di-AMP VacciGrade™ | An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit... | 2021 | Vaccines (Basel) | Cao H. et al. | DOI: 10.3390/vaccines9111261 |
| Poly(I:C) LMW | Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune re... | 2021 | Cancer Immunol Immunother | Hänel G. et al. | DOI: 10.1007/s00262-021-03109-w |
| R848 (Resiquimod) | Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune re... | 2021 | Cancer Immunol Immunother | Hänel G. et al. | DOI: 10.1007/s00262-021-03109-w |
| Normocin™ - Antimicrobial Reagent | CAF promotes chemoresistance through NRP2 in gastric cancer. | 2021 | Gastric Cancer | Yang Y. et al. | DOI: 10.1007/s10120-021-01270-w |
| Pam3CSK4 | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| Poly(I:C) HMW | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| QUANTI-Luc™ | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| R848 (Resiquimod) | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| QUANTI-Blue™ | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| THP1-Dual™ Cells | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| Zeocin® | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| Blasticidin | Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward ... | 2021 | Adv Sci (Weinh) | Sun L. et al. | DOI: 10.1002/advs.202104051 |
| HEK-Blue™ hTLR7 | MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons ... | 2021 | Mol Neurodegener | Wallach T. et al. | DOI: 10.1186/s13024-021-00498-5 |
| LyoVec™ | MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons ... | 2021 | Mol Neurodegener | Wallach T. et al. | DOI: 10.1186/s13024-021-00498-5 |
| HEK-Blue™ Detection | MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons ... | 2021 | Mol Neurodegener | Wallach T. et al. | DOI: 10.1186/s13024-021-00498-5 |